氟芬那酸通过协同离子调节使MRSA对庆大霉素重新敏感
该研究评估氟芬那酸增强庆大霉素抗MRSA活性的能力并阐明机制。体外实验显示氟芬那酸将庆大霉素对MRSA的MIC从32 mg/L降至1 mg/L,加速杀菌,机制涉及干扰Ca2+和Cl-内流、膜去极化、代谢扰动、ROS增加及结合Bap蛋白。加利eria mellonella感染模型中联合治疗较单用庆大霉素显著改善生存。
要点
- 氟芬那酸使庆大霉素对MRSA的MIC从32 mg/L降至1 mg/L。
- 机制包括破坏离子稳态、膜电位和生物膜结构。
- 动物模型中联合治疗生存优于单用庆大霉素。
核心结论
- 氟芬那酸作为协同离子调节剂,通过破坏膜完整性、离子稳态和生物膜结构使MRSA对庆大霉素重新敏感。
研究设计与样本
- 采用肉汤微量稀释法、时间杀伤试验和生物膜抑制试验评估氟芬那酸联合庆大霉素的抗菌活性。
- 机制研究包括离子流测定、膜电位和电荷测量、代谢谱分析、ROS检测及针对生物膜相关蛋白Bap的分子对接。
- efficacy further examined in a Galleria mellonella infection model.
主要发现
- 氟芬那酸将庆大霉素对MRSA的MIC从32 mg/L降至1 mg/L并加速杀菌。
- 氟芬那酸干扰Ca2+和Cl-内流,导致膜去极化和阴离子表面电荷增加,促进庆大霉素摄取。
- 氟芬那酸诱导代谢扰动、增强ROS生成,并与Bap结合(结合能:-7.678 kcal/mol),减少生物膜淀粉样蛋白含量并增加膜通透性。
- 在Galleria mellonella感染模型中,氟芬那酸/庆大霉素联合较单用庆大霉素显著改善生存。
临床怎么用
- 氟芬那酸有望作为辅助治疗用于难治性MRSA感染,但需进一步临床研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: The increasing prevalence of MRSA challenges current therapeutic options and underscores the need for strategies that restore the efficacy of existing antibiotics. To evaluate the ability of flufenamic acid to enhance gentamicin activity against MRSA and to elucidate its mechanism of action. METHODS: The antibacterial activity of flufenamic acid combined with gentamicin was assessed by broth microdilution, time-kill assays and biofilm inhibition tests. Mechanistic studies included ion flux assays, membrane potential and charge measurements, metabolic profiling, reactive oxygen species (ROS) detection, and molecular docking against the biofilm-associated protein Bap. Efficacy was further examined in a Galleria mellonella infection model. RESULTS: Flufenamic acid reduced the MIC of gentamicin against MRSA from 32 mg/L to 1 mg/L and accelerated bactericidal killing. It disrupted Ca2+ and Cl- influx, leading to membrane depolarization and increased anionic surface charge, thereby promoting gentamicin uptake. Flufenamic acid also induced metabolic perturbation, enhanced ROS generation, and bound to Bap (binding energy: -7.678 kcal/mol), reducing biofilm amyloid content and increasing membrane permeability. In Galleria mellonella, the flufenamic acid/gentamicin combination significantly improved survival compared with gentamicin alone. CONCLUSIONS: Flufenamic acid acts as a synergistic ion modulator that resensitizes MRSA to gentamicin via disruption of membrane integrity, ion homeostasis and biofilm structure, supporting its potential as an adjunctive therapy against difficult-to-treat MRSA infections.
引用
- Ren X, Wu S, Rafique A, et al. Flufenamic acid resensitizes MRSA to gentamicin through synergistic ion modulation. J Antimicrob Chemother. 2026. PMID: 42130030. doi:10.1093/jac/dkag154
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。